DDX32, or DEAH-box helicase 32, is a member of the broad family of DEAD-box RNA helicases, playing an essential role in various cellular processes related to RNA metabolism. The DEAD-box family is characterized by its ability to disrupt the secondary structure of RNA, which is crucial for several biological processes, including translation initiation, nuclear and mitochondrial splicing, and ribosome and spliceosome assembly. The expression of DDX32 is universal, with noticeable expression in the testis and colon. The protein's exact role and regulatory mechanisms remain areas of active study, as understanding these can shed light on its cellular functions and involvement in various biological processes.
The expression of DDX32 may be induced by several chemicals, directly or indirectly, although this is largely speculative based on our current understanding of cellular biology. Several compounds known to induce stress responses, cellular growth, or differentiation might affect the expression of DDX32. For instance, retinoic acid, a metabolite of vitamin A, known to stimulate cellular differentiation, might drive an increase in DDX32 expression. Similarly, Epidermal Growth Factor (EGF), which promotes cell growth and differentiation, could elevate DDX32 expression to meet increased cellular demands for RNA metabolism. Some compounds, like dexamethasone, a potent glucocorticoid, could increase DDX32 expression as part of extensive alterations to cellular stress responses. Sodium butyrate, might stimulate DDX32 expression due to broad epigenetic alterations to gene expression. Notably, these compounds are not specific to DDX32 and can have multiple effects on cells.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can stimulate cellular differentiation and might drive an upsurge in DDX32 expression as part of cellular adaptation to these changes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a potent glucocorticoid, could bring about an increase in DDX32 expression as part of its extensive alterations to cellular stress responses. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin, by escalating cAMP levels and subsequently activating PKA, could potentially stimulate DDX32 expression due to changes in RNA metabolism. | ||||||
Hydrogen Peroxide | 7722-84-1 | sc-203336 sc-203336A sc-203336B | 100 ml 500 ml 3.8 L | $31.00 $61.00 $95.00 | 28 | |
As a reactive oxygen species, hydrogen peroxide can induce oxidative stress and might promote an increase in DDX32 expression as part of the cellular response to oxidative stress. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a histone deacetylase inhibitor, could potentially stimulate DDX32 expression due to its broad epigenetic alterations to gene expression. | ||||||
Sodium (meta)arsenite | 7784-46-5 | sc-250986 sc-250986A | 100 g 1 kg | $108.00 $780.00 | 3 | |
Sodium arsenite, known to induce oxidative stress and heat shock proteins, could potentially increase DDX32 expression as part of the stress response. | ||||||
Mifepristone | 84371-65-3 | sc-203134 | 100 mg | $61.00 | 17 | |
Mifepristone, a glucocorticoid receptor antagonist, could potentially upregulate DDX32 expression by altering the cellular response to stress. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor and phytoestrogen, could potentially induce an upregulation in DDX32 expression due to its effects on various cellular pathways. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin, could potentially stimulate an increase in DDX32 expression due to its intercalation into DNA causing widespread changes in gene expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D, an inhibitor of DNA transcription, could potentially induce an upregulation of DDX32 expression as a compensatory response to reduced transcription activity. | ||||||